Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Argus Health
Healthtrust
McKesson
US Department of Justice
Medtronic
Cantor Fitzgerald
AstraZeneca
Merck

Generated: January 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204197

« Back to Dashboard

NDA 204197 describes CELECOXIB, which is a drug marketed by Alembic Pharms Ltd, Apotex Inc, Aurobindo Pharma Ltd, Cipla Ltd, Jubilant Generics, Lupin Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Teva, Torrent Pharms Ltd, and Watson Labs Inc, and is included in eleven NDAs. It is available from forty suppliers. Additional details are available on the CELECOXIB profile page.

The generic ingredient in CELECOXIB is celecoxib. There are twenty-six drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the celecoxib profile page.
Summary for 204197
Tradename:CELECOXIB
Applicant:Apotex Inc
Ingredient:celecoxib
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 204197
Medical Subject Heading (MeSH) Categories for 204197
Suppliers and Packaging for NDA: 204197
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CELECOXIB celecoxib CAPSULE;ORAL 204197 ANDA Major Pharmaceuticals 0904-6502 0904-6502-61 100 CAPSULE in 1 BOX, UNIT-DOSE (0904-6502-61)
CELECOXIB celecoxib CAPSULE;ORAL 204197 ANDA Major Pharmaceuticals 0904-6503 0904-6503-61 100 CAPSULE in 1 BOX, UNIT-DOSE (0904-6503-61)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength50MG
Approval Date:Jun 2, 2015TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Jun 2, 2015TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength200MG
Approval Date:Jun 2, 2015TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Chinese Patent Office
Cantor Fitzgerald
UBS
Cipla
Harvard Business School
Federal Trade Commission
Moodys
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot